Sanuwave Health Net Common Equity Issued/Repurchased 2010-2025 | SNWV
Sanuwave Health net common equity issued/repurchased from 2010 to 2025. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
| Sanuwave Health Annual Net Common Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2024 | $10 |
| 2023 | $N/A |
| 2022 | $0 |
| 2021 | $N/A |
| 2020 | $22 |
| 2019 | $5 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $3 |
| 2015 | $N/A |
| 2014 | $1 |
| 2013 | $2 |
| 2012 | $0 |
| 2011 | $12 |
| 2010 | $2 |
| 2009 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.239B | $0.033B |
| SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.294B | 27.81 |
| Boston Scientific (BSX) | United States | $157.073B | 39.32 |
| Stryker (SYK) | United States | $146.485B | 30.63 |
| EssilorLuxottica (ESLOY) | France | $131.510B | 0.00 |
| Medtronic (MDT) | Ireland | $104.117B | 14.76 |
| Haleon (HLN) | United Kingdom | $50.587B | 28.80 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.544B | 0.00 |
| ResMed (RMD) | United States | $36.103B | 27.12 |
| GE HealthCare Technologies (GEHC) | United States | $32.514B | 15.44 |
| Agilent Technologies (A) | United States | $31.721B | 20.95 |
| Terumo (TRUMY) | Japan | $28.131B | 36.54 |
| Insulet (PODD) | United States | $22.987B | 90.23 |
| Koninklijke Philips (PHG) | Netherlands | $21.694B | 15.60 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.639B | 11.97 |
| Baxter (BAX) | United States | $15.842B | 11.83 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.666B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.269B | 21.81 |
| Lantheus Holdings (LNTH) | United States | $5.242B | 13.22 |
| Prestige Consumer Healthcare (PBH) | United States | $4.244B | 18.96 |
| Perrigo (PRGO) | Ireland | $3.757B | 9.52 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.266B | 14.88 |
| ICU Medical (ICUI) | United States | $3.210B | 23.67 |
| Envista Holdings (NVST) | United States | $3.051B | 25.35 |
| GN Store Nord (GNNDY) | Denmark | $2.163B | 17.92 |
| QuidelOrtho (QDEL) | United States | $2.114B | 14.54 |
| LeMaitre Vascular (LMAT) | United States | $1.868B | 41.76 |
| AtriCure (ATRC) | United States | $1.683B | 0.00 |
| Neogen (NEOG) | United States | $1.335B | 17.08 |
| Acuren (TIC) | United States | $1.317B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.256B | 12.75 |
| Kestra Medical Technologies (KMTS) | United States | $1.156B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.120B | 25.19 |
| BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.919B | 9.26 |
| Evolus (EOLS) | United States | $0.633B | 0.00 |
| CeriBell (CBLL) | United States | $0.625B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.590B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.568B | 0.00 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Owens & Minor (OMI) | United States | $0.509B | 4.22 |
| Capricor Therapeutics (CAPR) | United States | $0.479B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.446B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.324B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.86 |
| Canopy Growth (CGC) | Canada | $0.313B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.307B | 54.70 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.261B | 22.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.11 |
| Cerus (CERS) | United States | $0.241B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.237B | 0.00 |
| Biote (BTMD) | United States | $0.223B | 6.28 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.207B | 0.00 |
| Brainsway (BWAY) | Israel | $0.201B | 53.25 |
| Quanterix (QTRX) | United States | $0.197B | 0.00 |
| Omeros (OMER) | United States | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.46 |
| Exagen (XGN) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.69 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Agape ATP (ATPC) | $0.092B | 0.00 | |
| Fonar (FONR) | United States | $0.089B | 11.42 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.47 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.86 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |